[1]	Lee S, Farwell AP. Euthyroid sick syndrome[J]. Compr Physiol, 2016, 6(2):1071-1080.DOI:10.1002/cphy.c150017. Cited in this article [1]

[2]	中华医学会内分泌学分会. 成人甲状腺功能减退症诊治指南[J]. 中华内分泌代谢杂志, 2017(2):167-180.DOI:10.3760/cma.j.issn.1000-6699.2017.02.018. Cited in this article [2]

[3]	Fliers E, Boelen A. An update on non-thyroidal illness syndrome[J]. J Endocrinol Invest, 2021, 44(8):1597-1607.DOI:10.1007/s40618-020-01482-4. Cited in this article [2]

[4]	Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock(sepsis-3)[J]. JAMA, 2016, 315(8):801-810.DOI:10.1001/jama.2016.0287. Cited in this article [1]

[5]	Xie J, Wang H, Kang Y, et al. The epidemiology of sepsis in Chinese ICUs:a national cross-sectional survey[J]. Crit Care Med, 2020, 48(3):e209-e218.DOI:10.1097/ccm.0000000000004155. Cited in this article [1]

[6]	Ray DC, Macduff A, Drummond GB, et al. Endocrine measurements in survivors and non-survivors from critical illness[J]. Intensive Care Med, 2002, 28(9):1301-1308.DOI:10.1007/s00134-002-1427-y. Cited in this article [1]

[7]	曾媛媛, 谢云, 陈道南, 等. 脓毒症患者发生正常甲状腺性病态综合征的相关因素[J]. 北京大学学报(医学版), 2024, 56(3):526-532.DOI:10.19723/j.issn.1671-167X.2024.03.021. Cited in this article [2]

[8]	王庭槐. 生理学[M]. 9版. 北京: 人民卫生出版社, 2018. Cited in this article [2]

[9]	Bianco AC, Kim BW. Deiodinases:implications of the local control of thyroid hormone action[J]. J Clin Invest, 2006, 116(10):2571-2579.DOI:10.1172/jci29812. Cited in this article [1]

[10]	Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome:an update[J]. J Endocrinol, 2010, 205(1):1-13.DOI:10.1677/joe-09-0412. Cited in this article [7]

[11]	Visser TJ. Thyroid hormone transporters[J]. Horm Res, 2007, 68(Suppl 5):28-30.DOI:10.1159/000110469. Cited in this article [1]

[12]	Visser WE, Friesema EC, Jansen J, et al. Thyroid hormone transport in and out of cells[J]. Trends Endocrinol Metab, 2008, 19(2):50-56.DOI:10.1016/j.tem.2007.11.003. Cited in this article [1]

[13]	Dayan CM, Panicker V. Novel insights into thyroid hormones from the study of common genetic variation[J]. Nat Rev Endocrinol, 2009, 5(4):211-218.DOI:10.1038/nrendo.2009.19. Cited in this article [1]

[14]	Davis PJ, Davis FB, Lin HY. Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors[J]. Steroids, 2008, 73(9-10):1013-1017.DOI:10.1016/j.steroids.2007.12.030. Cited in this article [1]

[15]	Oetting A, Yen PM. New insights into thyroid hormone action[J]. Best Pract Res Clin Endocrinol Metab, 2007, 21(2):193-208.DOI:10.1016/j.beem.2007.04.004. Cited in this article [1]

[16]	Inan M, Koyuncu A, Aydin C, et al. Thyroid hormone supplementation in sepsis:an experimental study[J]. Surg Today, 2003, 33(1):24-29.DOI:10.1007/s005950300004. Cited in this article [1]

[17]	Hesch RD, Hüsch M, Ködding R, et al. Treatment of dopamine-dependent shock with triiodothyronine[J]. Endocr Res Commun, 1981, 8(4):229-237.DOI:10.3109/07435808109045741. Cited in this article [1]

[18]	徐梅先, 刘刚, 曹利静, 等. 脓毒症危重患儿非甲状腺疾病综合征的发生及其与IL-6和IL-10的相关性[J]. 中国当代儿科杂志, 2020, 22(11):1215-1220.DOI:10.7499/j.issn.1008-8830.2004137. Cited in this article [1]

[19]	Yildizdaş D, Onenli-Mungan N, Yapicioqlu H,et al. Thyroid hormone levels and their relationship to survival in children with bacterial sepsis and septic shock[J]. J Pediatr Endocrinol Metab,2004,17(10):1435-1442.DOI:10.1515/jpem.2004.17.10.1435. Cited in this article [1]

[20]	Purwanto D, Astrawinata D. Mekanisme kompleks sepsis dan syok septik[J]. J Biomedika dan Biosains, 2018, 10(3):143.DOI:10.35790/jbm.10.3.2018.21979. Cited in this article [1]

[21]	周易, 陈影, 陈尔真. 甲状腺激素对脓毒症脏器功能维护作用的研究进展[J]. 内科理论与实践, 2022, 17(5):408-412.DOI:10.16138/j.1673-6087.2022.05.013. Cited in this article [1]

[22]	王凤, 严宗逊. 正常甲状腺病态综合征研究进展[J]. 中国医药导刊, 2020, 22(8):544-548.DOI:10.3969/j.issn.1009-0959.2020.08.011. Cited in this article [3]

[23]	Wasyluk W, Wasyluk M, Zwolak A. Sepsis as a pan-endocrine illness-endocrine disorders in septic patients[J]. J Clin Med, 2021, 10(10):2075-2075.DOI:10.3390/jcm10102075. Cited in this article [1]

[24]	Schett G, Neurath MF. Resolution of chronic inflammatory disease:universal and tissue-specific concepts[J]. Nat Commun, 2018, 9(1):3261.DOI:10.1038/s41467-018-05800-6. Cited in this article [2]

[25]	Medzhitov R. Origin and physiological roles of inflammation[J]. Nature, 2008, 454(7203):428-435.DOI:10.1038/nature07201. Cited in this article [1]

[26]	Lasa M, Contreras-Jurado C. Thyroid hormones act as modulators of inflammation through their nuclear receptors[J]. Front Endocrinol(Lausanne), 2022, 13:937099.DOI:10.3389/fendo.2022.937099. Cited in this article [4]

[27]	Hotchkiss RS, Moldawer LL, Opal SM, et al. Sepsis and septic shock[J]. Nat Rev Dis Primers, 2016, 2:16045.DOI:10.1038/nrdp.2016.45. Cited in this article [1]

[28]	Bartalena L, Bogazzi F, Brogioni S, et al. Role of cytokines in the pathogenesis of the euthyroid sick syndrome[J]. Eur J Endocrinol, 1998, 138(6):603-614.DOI:10.1530/eje.0.1380603. Cited in this article [1]

[29]	Siampa VN, Abadi S, Aman AM, et al. Association between severity of sepsis and thyroid function profile[J]. Acta Biomed, 2023, 94(6):e2023239.DOI:10.23750/abm.v94i6.15076. Cited in this article [3]

[30]	Vidart J, Axelrud L, Braun AC, et al. Relationship among low T3 levels,type 3 deiodinase,oxidative stress,and mortality in sepsis and septic shock:defining patient outcomes[J]. Int J Mol Sci, 2023, 24(4):3935.DOI:10.3390/ijms24043935. Cited in this article [2]

[31]	Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM. Association between serum interleukin-6 and serum 3,5,3’-triiodothyronine in nonthyroidal illness[J]. J Clin Endocrinol Metab, 1993, 77(6):1695-1699.DOI:10.1210/jcem.77.6.8263160. Cited in this article [2]

[32]	Mönig H, Arendt T, Meyer M, et al. Activation of the hypothalamo-pituitary-adrenal axis in response to septic or non-septic diseases-implications for the euthyroid sick syndrome[J]. Intensive Care Med, 1999, 25(12):1402-1406.DOI:10.1007/s001340051088. Cited in this article [1]

[33]	Boelen A, Platvoet-Ter Schiphorst MC, Bakker O, et al. The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice[J]. J Endocrinol, 1995, 146(3):475-483.DOI:10.1677/joe.0.1460475. Cited in this article [1]

[34]	Van Haasteren GA, Van Der Meer MJ, Hermus AR, et al. Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysial-thyroid axis[J]. Endocrinology, 1994, 135(4):1336-1345.DOI:10.1210/endo.135.4.7925094. Cited in this article [1]

[35]	Stouthard JM, Van Der Poll T, Endert E, et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans[J]. J Clin Endocrinol Metab, 1994, 79(5):1342-1346.DOI:10.1210/jcem.79.5.7962327. Cited in this article [1]

[36]	Hermus AR, Sweep CG, Demacker PN, et al. Continuous infusion of interleukin-1 beta in rats induces a profound fall in plasma levels of cholesterol and triglycerides[J]. Arterioscler Thromb, 1992, 12(9):1036-1043.DOI:10.1161/01.atv.12.9.1036. Cited in this article [1]

[37]	Van Der Poll T, Van Zee KJ, Endert E, et al. Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man[J]. J Clin Endocrinol Metab, 1995, 80(4):1341-1346.DOI:10.1210/jcem.80.4.7714108. Cited in this article [1]

[38]	Van Der Poll T, Endert E, Coyle SM, et al. Neutralization of TNF does not influence endotoxininduced changes in thyroid hormone metabolism in humans[J]. Am J Physiol, 1999, 276(2):R357-R362.DOI:10.1152/ajpregu.1999.276.2.R357. Cited in this article [1]

[39]	Rubingh J, Van Der Spek A, Fliers E, et al. The role of thyroid hormone in the innate and adaptive immune response during infection[J]. Compr Physiol, 2020, 10(4):1277-1287.DOI:10.1002/cphy.c200003. Cited in this article [1]

[40]	De Castro AL, Fernandes RO, Ortiz VD, et al. Thyroid hormones decrease the proinflammatory TLR4/NF-κβ pathway and improve functional parameters of the left ventricle of infarcted rats[J]. Mol Cell Endocrinol, 2018, 461:132-142.DOI:10.1016/j.mce.2017.09.003. Cited in this article [1]

[41]	Furuya F, Ishii T, Tamura S, et al. The ligand-bound thyroid hormone receptor in macrophages ameliorates kidney injury via inhibition of nuclear factor-κB activities[J]. Sci Rep, 2017, 7:43960.DOI:10.1038/srep43960. Cited in this article [1]

[42]	Contreras-Jurado C, Alonso-Merino E, Saiz-Ladera C, et al. The thyroid hormone receptors inhibit hepatic interleukin-6 signaling during endotoxemia[J]. Sci Rep, 2016, 6:30990.DOI:10.1038/srep30990. Cited in this article [1]

[43]	Alamino VA, Montesinos MDM, Soler MF, et al. Dendritic cells exposed to triiodothyronine deliver pro-inflammatory signals and amplify IL-17-driven immune responses[J]. Cell Physiol Biochem, 2019, 52(2):354-367.DOI:10.33594/000000025. Cited in this article [1]

[44]	Perrotta C, Buldorini M, Assi E, et al. The thyroid hormone triiodothyronine controls macrophage maturation and functions:protective role during inflammation[J]. Am J Pathol, 2014, 184(1):230-247.DOI:10.1016/j.ajpath.2013.10.006. Cited in this article [1]

[45]	Takano APC, Munhoz CD, Moriscot AS, et al. S100A8/MYD88/NF-кB:a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone[J]. J Mol Med(Berl), 2017, 95(6):671-682.DOI:10.1007/s00109-017-1511-y. Cited in this article [1]

[46]

Chiloeches A, Sánchez-Pacheco A, Gil-Araujo B, et al. Thyroid hormone-mediated activation of the ERK/dual specificity phosphatase 1 pathway augments the apoptosis of GH4C1 cells by down-regulating nuclear factor-kappaB activity[J]. Mol Endocrinol, 2008, 22(11):2466-2480.DOI:10.1210/me.2008-0107. Cited in this article [1]

[47]	Lasa M, Gil-Araujo B, Palafox M, et al. Thyroid hormone antagonizes tumor necrosis factor-alpha signaling in pituitary cells through the induction of dual specificity phosphatase 1[J]. Mol Endocrinol, 2010, 24(2):412-422.DOI:10.1210/me.2009-0298. Cited in this article [1]

[48]	Mussbacher M, Salzmann M, Brostjan C, et al. Cell type-specific roles of NF-κB linking inflammation and thrombosis[J]. Front Immunol, 2019, 10:85.DOI:10.3389/fimmu.2019.00085. Cited in this article [1]

[49]	Dorrington MG, Fraser IDC. NF-κB signaling in macrophages:dynamics,crosstalk,and signal integration[J]. Front Immunol, 2019, 10:705.DOI:10.3389/fimmu.2019.00705. Cited in this article [1]

[50]	Viatour P, Merville MP, Bours V, et al. Phosphorylation of NF-kappaB and IkappaB proteins:implications in cancer and inflammation[J]. Trends Biochem Sci, 2005, 30(1):43-52.DOI:10.1016/j.tibs.2004.11.009. Cited in this article [1]

[51]	Sabio G, Davis RJ. TNF and MAP kinase signalling pathways[J]. Semin Immunol, 2014, 26(3):237-245.DOI:10.1016/j.smim.2014.02.009. Cited in this article [1]

[52]	Taniguchi K, Karin M. NF-κB,inflammation,immunity and cancer:coming of age[J]. Nat Rev Immunol, 2018, 18(5):309-324.DOI:10.1038/nri.2017.142. Cited in this article [1]

[53]	Canovas B, Nebreda AR. Diversity and versatility of p38 kinase signalling in health and disease[J]. Nat Rev Mol Cell Biol, 2021, 22(5):346-366.DOI:10.1038/s41580-020-00322-w. Cited in this article [1]

[54]	Hui L, Yao Y, Wang S, et al. Inhibition of Janus kinase 2 and signal transduction and activator of transcription 3 protect against cecal ligation and puncture-induced multiple organ damage and mortality[J]. J Trauma, 2009, 66(3):859-865.DOI:10.1097/TA.0b013e318164d05f. Cited in this article [1]

[55]	李莉, 吴彩军. 危重症患者低T3综合征研究进展[J]. 中国急救医学, 2019, 39(2):165-169.DOI:10.3969/j.issn.1002-1949.2019.02.019. Cited in this article [1]

[56]	De Vries EM, Surovtseva O, Vos WG, et al. Downregulation of type 3 deiodinase in the hypothalamus during inflammation[J]. Thyroid, 2019, 29(9):1336-1343.DOI:10.1089/thy.2019.0201. Cited in this article [1]

[57]	Fekete C, Gereben B, Doleschall M, et al. Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus:implications for the nonthyroidal illness syndrome[J]. Endocrinology, 2004, 145(4):1649-1655.DOI:10.1210/en.2003-1439. Cited in this article [1]

[58]

Fekete C, Singru PS, Sarkar S, et al. Ascending brainstem pathways are not involved in lipopolysaccharide-induced suppression of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus[J]. Endocrinology, 2005, 146(3):1357-1363.DOI:10.1210/en.2004-1429. Cited in this article [1]

[59]	Prummel MF, Brokken LJ, Wiersinga WM. Ultra short-loop feedback control of thyrotropin secretion[J]. Thyroid, 2004, 14(10):825-829.DOI:10.1089/thy.2004.14.825. Cited in this article [1]

[60]	Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM. Soluble cytokine receptors and the low 3,5,3’-triiodothyronine syndrome in patients with nonthyroidal disease[J]. J Clin Endocrinol Metab, 1995, 80(3):971-976.DOI:10.1210/jcem.80.3.7883859. Cited in this article [2]

[61]	Boelen A, Schiphorst MC, Wiersinga WM. Relationship between serum 3,5,3’-triiodothyronine and serum interleukin-8,interleukin-10 or interferon gamma in patients with nonthyroidal illness[J]. J Endocrinol Invest, 1996, 19(7):480-483.DOI:10.1007/bf03349894.

[62]	Boelen A, Kwakkel J, Platvoet-Ter Schiphorst M, et al. Contribution of interleukin-12 to the pathogenesis of non-thyroidal illness[J]. Horm Metab Res, 2004, 36(2):101-106.DOI:10.1055/s-2004-814219. Cited in this article [1]

[63]	Rimmelé T, Kellum JA. Clinical review:blood purification for sepsis[J]. Crit Care, 2011, 15(1):205.DOI:10.1186/cc9411. Cited in this article [1]

[64]	Peng Z, Singbartl K, Simon P, et al. Blood purification in sepsis:a new paradigm[J]. Contrib Nephrol, 2010, 165:322-328.DOI:10.1159/000313773. Cited in this article [1]

[65]	Kim JG, Shin H, Kim W, et al. The value of decreased thyroid hormone for predicting mortality in adult septic patients:a systematic review and meta-analysis[J]. Sci Rep, 2018, 8(1):14137.DOI:10.1038/s41598-018-32543-7. Cited in this article [1]

[66]	Fliers E, Alkemade A, Wiersinga WM. The hypothalamic-pituitary-thyroid axis in critical illness[J]. Best Pract Res Clin Endocrinol Metab, 2001, 15(4):453-464.DOI:10.1053/beem.2001.0163. Cited in this article [1]

[67]	Fliers E, Alkemade A, Wiersinga WM, et al. Hypothalamic thyroid hormone feedback in health and disease[J]. Prog Brain Res, 2006, 153:189-207.DOI:10.1016/s0079-6123(06)53011-0. Cited in this article [1]

[68]	Fliers E, Boelen A, Van Trotsenburg AS. Central regulation of the hypothalamo-pituitary-thyroid(HPT)axis:focus on clinical aspects[J]. Handb Clin Neurol, 2014, 124:127-138.DOI:10.1016/b978-0-444-59602-4.00009-5. Cited in this article [1]

[69]	Sousa RHCE, Rorato R, Hollenberg AN, et al. Analysis of hypothalamic TRH neurons in regulating thyroid hormone levels[J]. Endocr Soc, 2021, 5(Supple1):A849.DOI:10.1210/jendso/bvab048.1733. Cited in this article [1]

[70]	Chan JL, Heist K, Depaoli AM, et al. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men[J]. J Clin Invest, 2003, 111(9):1409-1421.DOI:10.1172/jci17490. Cited in this article [1]

[71]	Bianco AC, Nunes MT, Hell NS, et al. The role of glucocorticoids in the stress-induced reduction of extrathyroidal 3,5,3’-triiodothyronine generation in rats[J]. Endocrinology, 1987, 120(3):1033-1038.DOI:10.1210/endo-120-3-1033. Cited in this article [1]

[72]	Nicoloff JT, Fisher DA, Appleman MD Jr. The role of glucocorticoids in the regulation of thyroid function in man[J]. J Clin Invest, 1970, 49(10):1922-1929.DOI:10.1172/jci106411. Cited in this article [1]

[73]	Alkemade A, Friesema EC, Unmehopa UA, et al. Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus[J]. J Clin Endocrinol Metab, 2005, 90(7):4322-4334.DOI:10.1210/jc.2004-2567. Cited in this article [1]

[74]	Boelen A, Kwakkel J, Alkemade A, et al. Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation[J]. Endocrinology, 2005, 146(12):5128-5134.DOI:10.1210/en.2005-0608. Cited in this article [1]

[75]	Hosoi Y, Murakami M, Mizuma H, et al. Expression and regulation of type Ⅱ iodothyronine deiodinase in cultured human skeletal muscle cells[J]. J Clin Endocrinol Metab, 1999, 84(9):3293-3300.DOI:10.1210/jcem.84.9.5969. Cited in this article [1]

[76]	Jakobs TC, Mentrup B, Schmutzler C, et al. Proinflammatory cytokines inhibit the expression and function of human type Ⅰ5’-deiodinase in HepG2 hepatocarcinoma cells[J]. Eur J Endocrinol, 2002, 146(4):559-566.DOI:10.1530/eje.0.1460559. Cited in this article [1]

[77]	Kwakkel J, Wiersinga WM, Boelen A. Interleukin-1beta modulates endogenous thyroid hormone receptor alpha gene transcription in liver cells[J]. J Endocrinol, 2007, 194(2):257-265.DOI:10.1677/joe-06-0177. Cited in this article [1]

[78]	Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome[J]. Ann Intern Med, 1993, 119(8):771-778.DOI:10.7326/0003-4819-119-8-199310150-00001. Cited in this article [1]

[79]	Wajner SM, Goemann IM, Bueno AL, et al. IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells[J]. J Clin Invest, 2011, 121(5):1834-1845.DOI:10.1172/jci44678. Cited in this article [1]

[80]	Lehnen TE, Marschner R, Dias F, et al. Oxidative remote induction of type 3 deiodinase impacts nonthyroidal illness syndrome[J]. J Endocrinol, 2020, 246(3):237-246.DOI:10.1530/joe-19-0574. Cited in this article [1]

[81]	Boelen A, Kwakkel J, Thijssen-Timmer DC, et al. Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice[J]. J Endocrinol, 2004, 182(2):315-323.DOI:10.1677/joe.0.1820315. Cited in this article [1]

[82]	Debaveye Y, Ellger B, Mebis L, et al. Regulation of tissue iodothyronine deiodinase activity in a model of prolonged critical illness[J]. Thyroid, 2008, 18(5):551-560.DOI:10.1089/thy.2007.0287. Cited in this article [1]

[83]	Peeters RP, Wouters PJ, Kaptein E, et al. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients[J]. J Clin Endocrinol Metab, 2003, 88(7):3202-3211.DOI:10.1210/jc.2002-022013. Cited in this article [1]

[84]	Kwakkel J, Surovtseva OV, De Vries EM, et al. A novel role for the thyroid hormone-activating enzyme type 2 deiodinase in the inflammatory response of macrophages[J]. Endocrinology, 2014, 155(7):2725-2734.DOI:10.1210/en.2013-2066. Cited in this article [1]

[85]	Boelen A, Wiersinga WM, Fliers E. Fasting-induced changes in the hypothalamus-pituitary-thyroid axis[J]. Thyroid, 2008, 18(2):123-129.DOI:10.1089/thy.2007.0253. Cited in this article [1]

[86]

Everts ME, De Jong M, Lim CF, et al. Different regulation of thyroid hormone transport in liver and pituitary:its possible role in the maintenance of low T3 production during nonthyroidal illness and fasting in man[J]. Thyroid, 1996, 6(4):359-368.DOI:10.1089/thy.1996.6.359. Cited in this article [2]

[87]	Jirasakuldech B, Schussler GC, Yap MG, et al. A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera[J]. J Clin Endocrinol Metab, 2000, 85(11):3996-3999.DOI:10.1210/jcem.85.11.6966. Cited in this article [1]

[88]	Reilly CP, Wellby ML. Slow thyroxine binding globulin in the pathogenesis of increased dialysable fraction of thyroxine in nonthyroidal illnesses[J]. J Clin Endocrinol Metab, 1983, 57(1):15-18.DOI:10.1210/jcem-57-1-15. Cited in this article [1]

[89]	Costante G, Sand G, Reding P, et al. Absence of circulating desialylated thyroxine-binding globulin in patients with hepatobiliary disease[J]. Acta Endocrinol(Copenh), 1985, 108(3):392-400.DOI:10.1530/acta.0.1080392. Cited in this article [1]

[90]	Bloise FF, Santos AT, De Brito J, et al. Sepsis impairs thyroid hormone signaling and mitochondrial function in the mouse diaphragm[J]. Thyroid, 2020, 30(7):1079-1090.DOI:10.1089/thy.2019.0124. Cited in this article [1]

[91]	Mebis L, Debaveye Y, Ellger B, et al. Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness[J]. Crit Care, 2009, 13(5):R147.DOI:10.1186/cc8043. Cited in this article [1]

[92]	Mebis L, Paletta D, Debaveye Y, et al. Expression of thyroid hormone transporters during critical illness[J]. Eur J Endocrinol, 2009, 161(2):243-250.DOI:10.1530/eje-09-0290. Cited in this article [2]

[93]	Phani Kumar AC, Arepalli S, Chintalapudi V, et al. Study of thyroid function in patients admitted in intensive care unit[J]. Int J Res Med Sci, 2022, 10(8):1806-1811.DOI:10.18203/2320-6012.ijrms20223258. Cited in this article [1]

[94]	Kothiwale VA, Patil P, Gaur S. Correlation of thyroid hormone profile with the acute physiology and chronic health evaluation Ⅱ score as a prognostic marker in patients with sepsis in the intensive care unit[J]. J Assoc Physicians India, 2018, 66(7):59-62. Cited in this article [1]

[95]	Li X, Zhu Z, Zhou T, et al. Predictive value of combined serum FGF21 and free T3 for survival in septic patients[J]. Clin Chim Acta, 2019, 494:31-37.DOI:10.1016/j.cca.2019.03.005. Cited in this article [1]

[96]	袁荆, 吴敬医, 鲁卫华, 等. 游离三碘甲状腺原氨酸联合血乳酸评估成人脓毒症患者的预后[J]. 齐齐哈尔医学院学报, 2023, 44(6):511-514.DOI:10.3969/j.issn.1002-1256.2023.06.003. Cited in this article [1]

[97]	徐跃文, 陈福进, 赵晶晶, 等. 基于重症监护医学信息数据库-Ⅳ分析低三碘甲状腺原氨酸综合征与脓毒症患者病死率的相关性[J]. 临床内科杂志, 2024, 41(3):179-183.DOI:10.3969/j.issn.1001-9057.2024.03.009. Cited in this article [1]

[98]	蒋天雨. 脓毒症早期甲状腺功能改变的特点及临床意义[D]. 天津: 天津医科大学, 2021.DOI:10.27366/d.cnki.gtyku.2021.000699. Cited in this article [1]

[99]	Liu YC, Jiang TY, Chen ZS, et al. Thyroid hormone disorders:a predictor of mortality in patients with septic shock defined by sepsis-3[J]. Intern Emerg Med, 2021, 16(4):967-973.DOI:10.1007/s11739-020-02546-2. Cited in this article [1]

[100]

Ning N, Li J, Sun W, et al. Different subtypes of nonthyroidal illness syndrome on the prognosis of septic patients:a two-centered retrospective cohort study[J]. Front Endocrinol(Lausanne), 2023, 14:1227530.DOI:10.3389/fendo.2023.1227530. Cited in this article [1]

[101]

Wang S, Chen M, Sun D, et al. Total triiodothyronine level associated with disease severity for patients with emergent status[J]. Sci Rep, 2024, 14(1):17170.DOI:10.1038/s41598-024-68195-z. Cited in this article [1]

[102]

Lado-Abeal J. Non-thyroidal illness syndrome,the hidden player in the septic shock induced myocardial contractile depression[J]. Med Hypotheses, 2020, 142:109775.DOI:10.1016/j.mehy.2020.109775. Cited in this article [1]

[103]

Kovacevic M, Adam VN, Causevic S. Triiodothyronine hormone supplementation therapy in septic shock patients with euthyroid sick syndrome:two pilot,placebo-controlled,randomized trials[J]. Anaesth Crit Care Pain Med, 2024, 43(2):101336.DOI:10.1016/j.accpm.2023.101336. Cited in this article [1]

[104]

Rocchi R, Kimura H, Tzou SC, et al. Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness[J]. Proc Natl Acad Sci U S A, 2007, 104(14):6019-6024.DOI:10.1073/pnas.0701319104. Cited in this article [1]

[105]

Van Den Berghe G. Non-thyroidal illness in the ICU:a syndrome with different faces[J]. Thyroid, 2014, 24(10):1456-1465.DOI:10.1089/thy.2014.0201. Cited in this article [1]

[106]

Van Den Berghe G, Wouters P, Weekers F, et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness[J]. J Clin Endocrinol Metab, 1999, 84(4):1311-1323.DOI:10.1210/jcem.84.4.5636. Cited in this article [2]

[107]

Van Den Berghe G, Baxter RC, Weekers F, et al. The combined administration of GH-releasing peptide-2(GHRP-2),TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone[J]. Clin Endocrinol(Oxf), 2002, 56(5):655-669.DOI:10.1046/j.1365-2265.2002.01255.x. Cited in this article [1]

[108]

Vidart J, Wajner SM, Leite RS, et al. N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction:a randomized clinical trial[J]. J Clin Endocrinol Metab, 2014, 99(12):4537-4545.DOI:10.1210/jc.2014-2192. Cited in this article [1]